Skip to main content
Veterinary Medicines

Amicel Varroa

Authorised
  • Amitraz

Product identification

Medicine name:
Amicel Varroa
AMICEL VARROA
Active substance:
  • Amitraz
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Amitraz
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for bee-hive strip
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
      • Honey
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AD01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • box containing 1 bottle of 1000 ml and 100 bee-hive strips
  • box containing 1 bottle of 250 ml and 25 bee-hive strips

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Maymo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Maymo S.A.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 3157 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0301/001
Concerned member states:
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/04/2023
Download
Spanish (PDF)
Published on: 4/06/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 4/06/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 4/06/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."